1. Ambrose PG, Bhavinani SM, Owen RC (2003) Clinical pharmacodynamics of quinolones. Infect Dis Clin North Am 17:529–543
2. Ambrose PG, Bhavnani SM, Rubino CM, Louie A, Gumbo T, Forrest A, Drusano GL (2007) Pharmacokinetics-pharmacodynamics of antimicrobial therapy: not just for mice anymore. Clin Infect Dis 44:79–86
3. Andes RD, Craig WA (1999) Pharmacodynamics of gemifloxacin (GEM) against quinolone-resistant strains of S. pneumoniae
4. (SP) with known resistance mechanisms. In: Proceedings and abstracts of the 39th interscience conference on antimicrobial agents and chemotherapy, American Society of Microbiology, Washington, DC, Abstract 2032, p 50
5. Andes D, Craig WA (2000) In vivo activities of amoxicillin and amoxicillin-clavulanate against Streptococcus pneumoniae: application to breakpoint determinations. Antimicrob Agents Chemother 44:1247–1254